Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the (a) supply and (b) availability of mefenamic acid for people in (i) the East of England and (ii) England.

The Department has a responsibility to work with United Kingdom medicine license holders to help ensure continuity of supply. We monitor and manage medicine supply issues at a national level so that stocks remain available to meet regional and local demand and therefore measures are not specific to the east of England.

We are aware of a supply issue with mefenamic acid 50 milligram/5 millilitre oral suspension which is expected to resolve in December 2025. Alternative formulations of mefenamic acid remain available, including capsules and tablets.

The Department will continue to work closely with the manufacturer to resolve the issue as soon as possible and to ensure patients have continuous access to medicines. Any patient who is worried about their condition should speak to their clinician in the first instance.